<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saeedi-Maleki Z</submitter><funding>Tabriz University of Medical Sciences</funding><pagination>27</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10935851</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Our objective was to compare the serum Adropin levels between patients with wet-type Age-Related Macular Degeneration (AMD) and otherwise healthy individuals.&lt;h4>Method&lt;/h4>The study included 45 patients with wet-type AMD and 45 individuals without age-related macular degeneration. Patients with co-morbidities such as diabetes, hypertension, autoimmune diseases, and a previous history of visual impairment; were excluded. FBS, Hemoglobin A1C (HbA1C), lipid profile, and serum Adropin level were checked.&lt;h4>Results&lt;/h4>The mean serum Adropin level of patients with wet-type AMD was significantly lower than the control group (P-value &lt; 0.001). Also, the mean High-sensitivity C-reactive protein ( hsCRP) level and High Density Lipoprotein (HDL) were significantly higher in wet-type AMD patients (P-value = 0.031 and &lt; 0.001 respectively).&lt;h4>Conclusions&lt;/h4>In our study, wet-type AMD was associated with a lower level of serum Adropin. Because of Adropin involvement in glucose metabolism and age-related changes, it may have a role in the pathogenesis of AMD, but it requires more investigations at the molecular level to elucidate its function.</pubmed_abstract><journal>International journal of retina and vitreous</journal><pubmed_title>Serum adropin level in wet-type age-related macular degeneration.</pubmed_title><pmcid>PMC10935851</pmcid><funding_grant_id>Tabriz University of Medical Sciences</funding_grant_id><pubmed_authors>Javadzadeh A</pubmed_authors><pubmed_authors>Mousavi F</pubmed_authors><pubmed_authors>Ghorbanihaghjo A</pubmed_authors><pubmed_authors>Brumandpur F</pubmed_authors><pubmed_authors>Saeedi-Maleki Z</pubmed_authors><pubmed_authors>Khanzadeh S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum adropin level in wet-type age-related macular degeneration.</name><description>&lt;h4>Purpose&lt;/h4>Our objective was to compare the serum Adropin levels between patients with wet-type Age-Related Macular Degeneration (AMD) and otherwise healthy individuals.&lt;h4>Method&lt;/h4>The study included 45 patients with wet-type AMD and 45 individuals without age-related macular degeneration. Patients with co-morbidities such as diabetes, hypertension, autoimmune diseases, and a previous history of visual impairment; were excluded. FBS, Hemoglobin A1C (HbA1C), lipid profile, and serum Adropin level were checked.&lt;h4>Results&lt;/h4>The mean serum Adropin level of patients with wet-type AMD was significantly lower than the control group (P-value &lt; 0.001). Also, the mean High-sensitivity C-reactive protein ( hsCRP) level and High Density Lipoprotein (HDL) were significantly higher in wet-type AMD patients (P-value = 0.031 and &lt; 0.001 respectively).&lt;h4>Conclusions&lt;/h4>In our study, wet-type AMD was associated with a lower level of serum Adropin. Because of Adropin involvement in glucose metabolism and age-related changes, it may have a role in the pathogenesis of AMD, but it requires more investigations at the molecular level to elucidate its function.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-27T03:17:31.293Z</modification><creation>2026-06-27T03:06:13.693Z</creation></dates><accession>S-EPMC10935851</accession><cross_references><pubmed>38475838</pubmed><doi>10.1186/s40942-024-00543-7</doi></cross_references></HashMap>